Joanna Horobin
2017 - Idera Pharmaceuticals
In 2017, Joanna Horobin earned a total compensation of $757.5K as Senior Vice President, Chief Medical Officer at Idera Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,840 |
|---|---|
| Option Awards | $182,924 |
| Salary | $410,000 |
| Other | $31,754 |
| Total | $757,518 |
Horobin received $410K in salary, accounting for 54% of the total pay in 2017.
Horobin also received $132.8K in non-equity incentive plan, $182.9K in option awards and $31.8K in other compensation.
Rankings
In 2017, Joanna Horobin's compensation ranked 10,252nd out of 14,666 executives tracked by ExecPay. In other words, Horobin earned more than 30.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,252 out of 14,666 | 30th |
Division Manufacturing | 3,973 out of 5,772 | 31st |
Major group Chemicals And Allied Products | 1,397 out of 2,075 | 33rd |
Industry group Drugs | 1,135 out of 1,731 | 34th |
Industry Biological Products, Except Diagnostic Substances | 204 out of 313 | 35th |
Source: SEC filing on April 25, 2019.
Horobin's colleagues
We found five more compensation records of executives who worked with Joanna Horobin at Idera Pharmaceuticals in 2017.
2017
Vincent Milano
Idera Pharmaceuticals
Chief Executive Officer
2017
Jonathan Yingling
Idera Pharmaceuticals
Chief Scientific Officer
2017
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
2017
Louis Arcudi
Idera Pharmaceuticals
Chief Financial Officer
2017
John Kirby
Idera Pharmaceuticals